Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2018) Vol. 65, pp. 37-55
Open Access | Times Cited: 886

Showing 1-25 of 886 citing articles:

Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 239
Fibrosis and alcohol-related liver disease
Carolin Lackner, Dina Tiniakos
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 294-304
Open Access | Times Cited: 231
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Xingpeng Di, Xiaoshuai Gao, Liao Peng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 145
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 144
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
Jianhua Rao, Hao Wang, Ming Ni, et al.
Gut (2022) Vol. 71, Iss. 12, pp. 2539-2550
Open Access | Times Cited: 130
Novel therapeutic targets for cholestatic and fatty liver disease
Michael Trauner, Claudia Fuchs
Gut (2021) Vol. 71, Iss. 1, pp. 194-209
Open Access | Times Cited: 129
The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury
Shahrbanoo Keshavarz Azizi Raftar, Fatemeh Ashrafian, Abbas Yadegar, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 108
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 80
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 57
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
Yunfeng Shen, Lidan Cheng, Minxuan Xu, et al.
Metabolism (2023) Vol. 146, pp. 155657-155657
Closed Access | Times Cited: 43
Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
Liang Shan, Fengling Wang, Dandan Zhai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114472-114472
Open Access | Times Cited: 42
Dietary gallic acid as an antioxidant: A review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions
Zedong Xiang, Huida Guan, Xiang Zhao, et al.
Food Research International (2024) Vol. 180, pp. 114068-114068
Closed Access | Times Cited: 34
Chronic arsenic exposure-provoked biotoxicity involved in liver-microbiota-gut axis disruption in chickens based on multi-omics technologies
Jiayi Li, Changming Guo, Yan Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 17
Pharmacological Activities of Plant‐Derived Fraxin with Molecular Mechanisms: A Comprehensive Review
Jannatul Ferdous, Md. Shimul Bhuia, Raihan Chowdhury, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access | Times Cited: 16
Design, Synthesis, and Biological Evaluation of a Potent and Orally Bioavailable FGFRs Inhibitor for Fibrotic Treatment
Yue Lin, Zui Tan, Wei Wei, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117232-117232
Closed Access | Times Cited: 1
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cells
Lixian Yang, Chuangye Qi, Lu Si, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Extracellular vesicles in Helicobacter pylori-mediated diseases: mechanisms and therapeutic potential
Jianjun Wang, Xiuping Wang, Hao Luo, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
STAT3: A key regulator in liver fibrosis
Jie Zhao, Yongfen Qi, Yan-Rong Yu
Annals of Hepatology (2020) Vol. 21, pp. 100224-100224
Open Access | Times Cited: 128
Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
Clara I. Colino, José M. Lanao, Carmen Gutiérrez Millán
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 127
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula
Hui Li
Journal of Ethnopharmacology (2019) Vol. 251, pp. 112442-112442
Closed Access | Times Cited: 126
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Erica Lafoz, Maria Ruart, Aina Anton, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 929-929
Open Access | Times Cited: 120
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
Claire McQuitty, Roger Williams, Shilpa Chokshi, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 105
Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells
Lu Wan, Tian Xia, Yanqin Du, et al.
The FASEB Journal (2019) Vol. 33, Iss. 7, pp. 8530-8542
Closed Access | Times Cited: 99
ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis
Beatrice Foglia, Stefania Cannito, Claudia Bocca, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2700-2700
Open Access | Times Cited: 85
Page 1 - Next Page

Scroll to top